[Federal Register Volume 85, Number 245 (Monday, December 21, 2020)]
[Notices]
[Page 83099]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-28046]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: Office of Infectious Disease and HIV/AIDS Policy, Office of the 
Assistant Secretary for Health, Office of the Secretary, Department of 
Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold a virtual 
meeting. The meeting will be open to the public and public comment will 
be heard during the meeting.

DATES: The meeting will be held February 4-5, 2021. The confirmed 
meeting times and agenda will be posted on the NVAC website at http://www.hhs.gov/nvpo/nvac/meetings/index.html as soon as they become 
available.

ADDRESSES: Instructions regarding attending this meeting will be posted 
online at: http://www.hhs.gov/nvpo/nvac/meetings/index.html at least 
one week prior to the meeting. Pre-registration is required for those 
who wish to attend the meeting or participate in public comment. Please 
register at http://www.hhs.gov/nvpo/nvac/meetings/index.html.

FOR FURTHER INFORMATION CONTACT: Ann Aikin, Acting Designated Federal 
Officer, at the Office of Infectious Disease and HIV/AIDS Policy, U.S. 
Department of Health and Human Services, Mary E. Switzer Building, Room 
L618, 330 C Street SW, Washington, DC 20024. Email: [email protected]. 
Phone: 202-695-9742.

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. 300aa-1), the Secretary of HHS was 
mandated to establish the National Vaccine Program to achieve optimal 
prevention of human infectious diseases through immunization and to 
achieve optimal prevention against adverse reactions to vaccines. The 
NVAC was established to provide advice and make recommendations to the 
Director of the National Vaccine Program on matters related to the 
Program's responsibilities. The Assistant Secretary for Health serves 
as Director of the National Vaccine Program.
    During this NVAC meeting, NVAC will hear presentations on vaccine 
safety, communication activities for COVID-19 vaccines, and 
immunization equity. Please note that agenda items are subject to 
change, as priorities dictate. Information on the final meeting agenda 
will be posted prior to the meeting on the NVAC website: http://www.hhs.gov/nvpo/nvac/index.html.
    Members of the public will have the opportunity to provide comment 
at the NVAC meeting during the public comment period designated on the 
agenda. Public comments made during the meeting will be limited to 
three minutes per person to ensure time is allotted for all those 
wishing to speak. Individuals are also welcome to submit written 
comments in advance. Written comments should not exceed three pages in 
length. Individuals submitting comments should email their written 
comments or their request to provide a comment during the meeting to 
[email protected] at least five business days prior to the meeting.

    Dated: October 27, 2020.
Ann Aikin,
Acting Designated Federal Official, Office of the Assistant Secretary 
for Health.
[FR Doc. 2020-28046 Filed 12-18-20; 8:45 am]
BILLING CODE 4150-44-P